Mumbai-based Wockhardt has completed phase 3 clinical trials in nearly 400 patients. Pharma firm looking to file for regulatory approvals in India, US and other countries in 2025.
Results outlined in study published in journal ‘Nature’ this month. The results are from animal studies, says the paper, adding that the drug is now being tested in humans.
‘First Multicentric Point Prevalence Survey of Antibiotic Use at 20 NAC-NET Sites India 2021-22’ conducted by National Centre for Disease Control under Union health ministry.
Commonly-sold cold and flu medicine such as Cheston Cold, ear drops Candibiotic and painkiller Etogesic among list, pharma industry wants those who prescribe FDC to judge efficacy.
From 2000 to 2015, TB claimed 33 million lives and cost the world economy an estimated $616 billion. By 2030, a further $1 trillion and 28 million lives may be lost.
Whether it is due to the alleged unofficial ban on The Bengal Files or allegations by Gopal Mukherjee’s family against Agnihotri, everyone in the state wants to know more about Mukherjee.
New Delhi: On 4 September morning, apple growers in south Kashmir’s Pulwama woke up to knee-deep water in their orchards, ripe apples scattered all over,...
New Delhi: Army chief General Upendra Dwivedi has strongly backed the idea of theaterisation, saying it is inevitable and the need of the hour.
Speaking...
In its toughest time in decades because of floods, Punjab would’ve expected PM Modi to visit. If he has the time for a Bihar tour, why not a short visit to next-door Punjab?
COMMENTS